Kobayashi Pharmaceutical Co's market cap is currently $2.76B. The company's EPS TTM is $0.897; its P/E ratio is 41.58; and it has a dividend yield of 1.78%. Kobayashi Pharmaceutical Co is scheduled to report earnings on February 10, 2025, and the estimated EPS forecast is $0.50. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 173.46B	¥ 166.26B	¥ 155.25B	¥ 150.51B	¥ 168.05B
Gross Profit	¥ 96.38B	¥ 92.33B	¥ 88.77B	¥ 85.27B	¥ 103.35B
Operating Income	¥ 25.78B	¥ 26.67B	¥ 26.07B	¥ 25.94B	¥ 26.36B
EBITDA	¥ 33.65B	¥ 31.86B	¥ 30.79B	¥ 29.91B	¥ 30.34B
Net Income	¥ 20.34B	¥ 20.02B	¥ 19.71B	¥ 19.20B	¥ 19.14B
Balance Sheet
Cash & Short-Term Investments	¥ 79.84B	¥ 104.53B	¥ 109.05B	¥ 94.34B	¥ 90.56B
Total Assets	¥ 267.47B	¥ 255.83B	¥ 252.55B	¥ 238.37B	¥ 233.40B
Total Debt	¥ 987.00M	¥ 792.00M	¥ 630.00M	¥ 688.00M	¥ 891.00M
Net Debt	¥ -70.55B	¥ -95.44B	¥ -94.39B	¥ -77.56B	¥ -74.69B
Total Liabilities	¥ 62.66B	¥ 57.93B	¥ 56.95B	¥ 55.78B	¥ 60.74B
Stockholders' Equity	¥ 204.82B	¥ 197.90B	¥ 195.60B	¥ 182.58B	¥ 172.66B
Cash Flow
Free Cash Flow	¥ 4.79B	¥ 15.69B	¥ 18.23B	¥ 19.84B	¥ 15.29B
Operating Cash Flow	¥ 18.36B	¥ 31.91B	¥ 22.42B	¥ 23.99B	¥ 20.09B
Investing Cash Flow	¥ -19.58B	¥ -14.31B	¥ 7.99B	¥ -12.66B	¥ -5.07B
Financing Cash Flow	¥ -19.46B	¥ -20.76B	¥ -10.38B	¥ -6.02B	¥ -14.58B

Currency in JPY

Kobayashi Pharmaceutical Co Earnings and Revenue History

Income Statement >

Kobayashi Pharmaceutical Co Debt to Assets

Balance Sheet >

Kobayashi Pharmaceutical Co Cash Flow

Cash Flow >

Kobayashi Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing